These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24503248)

  • 1. Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia.
    Ramma W; Ahmed A
    J Reprod Immunol; 2014 Mar; 101-102(100):153-160. PubMed ID: 24503248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms and therapeutic implications of the carbon monoxide/hmox1 and the hydrogen sulfide/CSE pathways in the prevention of pre-eclampsia and fetal growth restriction.
    Ahmed A
    Pregnancy Hypertens; 2014 Jul; 4(3):243-4. PubMed ID: 26104642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.
    Ahmed A
    Thromb Res; 2011 Feb; 127 Suppl 3():S72-5. PubMed ID: 21262447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?
    Ahmed A; Cudmore MJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1237-42. PubMed ID: 19909254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of statin as inducer of Hmox-1 system in treatment of preeclampsia.
    Putra RA; Effendi JS; Permadi W; Bandiara R; Fauziah PN
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):1-4. PubMed ID: 30084810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment.
    Rezai H; Ahmad S; Alzahrani FA; Sanchez-Aranguren L; Dias IH; Agrawal S; Sparatore A; Wang K; Ahmed A
    Redox Biol; 2021 Jan; 38():101768. PubMed ID: 33137710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
    Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
    EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia.
    Tan L; Kluivers ACM; Cruz-López EO; Broekhuizen M; Chen Z; Neuman RI; Schoenmakers S; Ruijgrok L; van de Velde D; de Winter BCM; van den Bogaerdt AJ; Lu X; Danser AHJ; Verdonk K
    Hypertension; 2024 Apr; 81(4):861-875. PubMed ID: 38361240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statins on preeclampsia: A systematic review.
    Vahedian-Azimi A; Karimi L; Reiner Ž; Makvandi S; Sahebkar A
    Pregnancy Hypertens; 2021 Mar; 23():123-130. PubMed ID: 33333432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating HO-1 levels are not associated with plasma sFLT-1 and GT
    Sandrim V; Coeli-Lacchini FB; Tanus-Santos JE; Lacchini R; Cavalli RC
    Hypertens Pregnancy; 2019 May; 38(2):73-77. PubMed ID: 30835584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Based Revised View of the Pathophysiology of Preeclampsia.
    Ahmed A; Rezai H; Broadway-Stringer S
    Adv Exp Med Biol; 2017; 956():355-374. PubMed ID: 27873232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y; Lewis DF; Wang Y
    J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.
    Hannan NJ; Brownfoot FC; Cannon P; Deo M; Beard S; Nguyen TV; Palmer KR; Tong S; Kaitu'u-Lino TJ
    Sci Rep; 2017 May; 7(1):1819. PubMed ID: 28500309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.